Attys Vie To Lead Investor Suit Against AI-Based Drugmaker
By Emilie Ruscoe ( September 7, 2023, 2:31 PM EDT) -- Seven legal teams have filed bids to represent a proposed class of investors in artificial intelligence-driven biopharmaceutical company BioXcel Therapeutics Inc. in a suit alleging that it hurt investors after announcing plans to investigate results of a study of one of its drugs....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.